Galanis, E., Anderson, S. K., Lafky, J. M., Uhm, J. H., Giannini, C., Kumar, S. K., . . . Buckner, J. C. (2013). Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial().
Chicago Style CitationGalanis, Evanthia, et al. Phase II Study of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial(). 2013.
MLA CitationGalanis, Evanthia, et al. Phase II Study of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial(). 2013.
Warning: These citations may not always be 100% accurate.